Ann Sarah Walker

492 total citations
7 papers, 29 citations indexed

About

Ann Sarah Walker is a scholar working on Infectious Diseases, Virology and Clinical Biochemistry. According to data from OpenAlex, Ann Sarah Walker has authored 7 papers receiving a total of 29 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Virology and 1 paper in Clinical Biochemistry. Recurrent topics in Ann Sarah Walker's work include HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Ann Sarah Walker is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Ann Sarah Walker collaborates with scholars based in United Kingdom, Uganda and United States. Ann Sarah Walker's co-authors include Immaculate Nankya, Diana M. Gibb, Paolo Denti, Veronica Mulenga, Addy Kekitiinwa, Jonathan Levin, Marshall Munjoma, Peter Mugyenyi, Emmanuel Ndashimye and Victor Musiime and has published in prestigious journals such as Nature Communications, Emerging infectious diseases and AIDS.

In The Last Decade

Ann Sarah Walker

5 papers receiving 27 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Sarah Walker United Kingdom 3 25 13 11 5 4 7 29
Maurizio Milesi Italy 4 24 1.0× 17 1.3× 17 1.5× 14 2.8× 4 1.0× 5 44
Blair Thedinger United States 3 44 1.8× 26 2.0× 19 1.7× 11 2.2× 4 1.0× 4 51
Hlanai Gumbo Zimbabwe 2 20 0.8× 10 0.8× 15 1.4× 2 0.4× 3 0.8× 3 27
Birhanu Wagaye Ethiopia 4 17 0.7× 8 0.6× 7 0.6× 2 0.4× 9 2.3× 10 41
Marie Varloteaux France 5 29 1.2× 13 1.0× 6 0.5× 12 2.4× 4 1.0× 10 40
Sandra Morenilla Spain 2 19 0.8× 16 1.2× 6 0.5× 2 0.4× 2 0.5× 5 23
Ethan Klock United States 3 17 0.7× 13 1.0× 11 1.0× 3 0.6× 5 19
B. Nyanzi Wakholi United Kingdom 2 23 0.9× 11 0.8× 8 0.7× 4 0.8× 5 1.3× 6 40
Jayne Gould United Kingdom 4 21 0.8× 7 0.5× 7 0.6× 2 0.4× 3 0.8× 5 37
C. Bernaud France 3 26 1.0× 20 1.5× 4 0.4× 8 1.6× 2 0.5× 3 30

Countries citing papers authored by Ann Sarah Walker

Since Specialization
Citations

This map shows the geographic impact of Ann Sarah Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Sarah Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Sarah Walker more than expected).

Fields of papers citing papers by Ann Sarah Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Sarah Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Sarah Walker. The network helps show where Ann Sarah Walker may publish in the future.

Co-authorship network of co-authors of Ann Sarah Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Sarah Walker. A scholar is included among the top collaborators of Ann Sarah Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Sarah Walker. Ann Sarah Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Peto, Tim, et al.. (2025). Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories. Nature Communications. 16(1). 4466–4466.
2.
3.
Schomaker, Michael, Paolo Denti, David M. Burger, et al.. (2024). Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS‐3 Trial. Pharmacoepidemiology and Drug Safety. 33(12). e70051–e70051. 1 indexed citations
4.
Vihta, Karina-Doris, et al.. (2023). Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022. Emerging infectious diseases. 29(10). 2024–2031. 1 indexed citations
5.
Denti, Paolo, Adrian Cook, Lubbe Wiesner, et al.. (2017). Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets. AIDS. 31(7). 905–915. 7 indexed citations
6.
Musiime, Victor, Phillip Kasirye, Patricia Nahirya-Ntege, et al.. (2016). Once vs twice-daily abacavir and lamivudine in African children. AIDS. 30(11). 1761–1770. 10 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Milesi Breakdown of academic impact, for papers by Blair Thedinger Breakdown of academic impact, for papers by Hlanai Gumbo Breakdown of academic impact, for papers by Birhanu Wagaye Breakdown of academic impact, for papers by Marie Varloteaux Breakdown of academic impact, for papers by Sandra Morenilla Breakdown of academic impact, for papers by Ethan Klock Breakdown of academic impact, for papers by B. Nyanzi Wakholi Breakdown of academic impact, for papers by Jayne Gould Breakdown of academic impact, for papers by C. Bernaud
Rankless by CCL
2026